Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AERIAL®: Changes in Health and Functional Status in Patients With COPD During Therapy With Spiolto® Respimat®

NCT03165045 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03165045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03165045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AERIAL®: Changes in Health and Functional Status in Patients With COPD During Therapy With Spiolto® Respimat®
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
May 26, 2017
Completion date
March 24, 2019
Enrollment
1,351 (actual)
Sites
108

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease, chronic obstructive